BioCentury
ARTICLE | Finance

Harbour continues flurry of deals with $102.8M series C round

July 11, 2020 12:27 AM UTC

On the back of multiple COVID-19 mAb deals and a $75 million series B+ round closed in March, Harbour BioMed has raised another $102.8 million via a series C round led by Hudson Bay Capital.

Fellow new investors OrbiMed Advisors, Country Garden VC, GTJA Investment Group, Octagon Capital and Sage Partners participated alongside existing investor Greater Bay Area Investment Fund...